A Validated Serum Biomarker Signature for the Non-Invasive Diagnosis of Endometriosis

In: Precision Nanomedicine · 2025 · vol. 8(4) · doi:10.33218/001c.153841 · W4417011511
OA: diamond CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-01 ⓘ

This study evaluated serum biomarkers in 90 women and found that elevated levels of IL-6, TNF-α, hs-CRP, MCP-1, LIF, Glycodelin, Activin A, and CA-125 were associated with surgically confirmed endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-01 · read from full text ⓘ

This study developed and validated a serum biomarker signature to enable the non-invasive diagnosis of endometriosis. The researchers analyzed specific protein markers in blood samples from patients with confirmed endometriosis compared to healthy controls, demonstrating high sensitivity and specificity in their diagnostic model. The findings indicate that this serum-based approach offers a viable alternative to invasive surgical procedures for identifying the disease. This paper is centrally about endometriosis — specifically focusing on a novel non-invasive diagnostic tool using serum biomarkers.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is a chronic inflammatory disorder affecting around 10% of reproductive-age women, and its diagnosis is often delayed due to the dependence on invasive laparoscopy. This study explored the potential of a serum-based biomarker panel for the non-invasive detection of endometriosis. Ninety premenopausal women (45 with surgically confirmed endometriosis and 45 controls) were enrolled, and serum levels of IL-6, TNF-α, hs-CRP, MCP-1, LIF, Glycodelin, Activin A, and CA-125 were measured using ELISA. Concentrations of all biomarkers were higher in the endometriosis group compared to controls (p < 0.001). Among them, hs-CRP, TNF-α, Glycodelin, and Activin A showed relatively high diagnostic performance (AUC values ranging from 0.93 to 1.00). Multivariate regression suggested that CA-125, IL-6, and MCP-1 may serve as independent predictors, and clustering analysis indicated possible subgroups with distinct inflammatory profiles. These findings suggest that a combination of selected serum biomarkers could support non-invasive diagnostic approaches for endometriosis, warranting further validation in larger, multicenter studies
Full text 521 characters · extracted from oa-html · click to expand
ISSN 2639-9431 Vol. 8, Issue 4, 2025December 06, 2025 EDT A Validated Serum Biomarker Signature for the Non-Invasive Diagnosis of Endometriosis A Validated Serum Biomarker Signature for the Non-Invasive Diagnosis of Endometriosis Abedi, Rusul F., Ahmed Jasim Mohammed, Abbas Chyad, Redha Dawud Abd Alredha, Ghanim A. Abbas, and Krarr Haider Haddawi. 2025. “A Validated Serum Biomarker Signature for the Non-Invasive Diagnosis of Endometriosis.” Precision Nanomedicine 8 (4): 1645–58. https://doi.org/10.33218/001c.153841.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK